Cite
MLA Citation
Guillermo Crespo et al.. “Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience.” Future oncology, vol. 13, 2017, pp. 615–624. http://access.bl.uk/ark:/81055/vdc_100154538205.0x00000f